NEW YORK (GenomeWeb) – OneOme and Rainbow Genomics today announced a deal to provide OneOme's RightMed pharmacogenomic test with Rainbow Genomics' whole-exome sequencing test services to patients in Hong Kong, Japan, and Macau.

The full OneOme RightMed platform will be offered by Rainbow to patients and physicians, the firms added.

Financial and other terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.